The Effect of Natural Molecules on HPV Infection
NCT06661083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2025-03-19
Summary
The purpose of the study is to evaluate the effect of the administration of natural molecules in the treatment of HPV infection.
Conditions
- HPV (Human Papillomavirus)-associated
Interventions
- DIETARY_SUPPLEMENT
-
EGCG, FA, HA, B12
EGCG + FA + HA + B12 (1 cps /die)
Sponsors & Collaborators
-
AGUNCO Obstetrics and Gynecology Centre
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2025-02-28
- Completion
- 2025-03-07
Countries
- Italy
Study Locations
More Related Trials
-
Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection
NCT06752083 ·Status: COMPLETED
-
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
NCT02382419 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase II Evaluation of AHCC for the Eradication of HPV Infections
NCT02405533 ·Status: COMPLETED ·Phase: NA
-
Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.
NCT06705322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tolerance and Effectiveness of C14 on HPV Infection
NCT06672653 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection
NCT01571141 ·Status: COMPLETED ·Phase: PHASE4
-
Carrageenan for the Prevention of Oral HPV Infection
NCT05746988 ·Status: UNKNOWN ·Phase: NA
-
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
NCT01468636 ·Status: TERMINATED ·Phase: PHASE4
-
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
NCT02376478 ·Status: COMPLETED
-
Zinc Sulfate for Human Papillomavirus (HPV)
NCT03404310 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients
NCT06199128 ·Status: COMPLETED
-
Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance
NCT04781023 ·Status: UNKNOWN ·Phase: NA
-
ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection
NCT06439433 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
NCT00829608 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis
NCT01375868 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
NCT06979180 ·Status: RECRUITING ·Phase: NA
-
Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female
NCT04633330 ·Status: RECRUITING ·Phase: NA
-
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
NCT04724980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
RTX-321 Monotherapy in Patients With HPV 16+ Tumors
NCT04672980 ·Status: TERMINATED ·Phase: PHASE1
-
SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
NCT01676792 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
NCT03911076 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test
NCT06188104 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
NCT02379520 ·Status: COMPLETED ·Phase: PHASE1
-
Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
NCT02631863 ·Status: COMPLETED ·Phase: PHASE2
-
Hespecta Vaccination in HPV+ Tumors or Malignant Lesions
NCT02821494 ·Status: COMPLETED ·Phase: PHASE1